IS8096A - Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum - Google Patents
Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpumInfo
- Publication number
- IS8096A IS8096A IS8096A IS8096A IS8096A IS 8096 A IS8096 A IS 8096A IS 8096 A IS8096 A IS 8096A IS 8096 A IS8096 A IS 8096A IS 8096 A IS8096 A IS 8096A
- Authority
- IS
- Iceland
- Prior art keywords
- agitation
- compound
- treat patient
- formula
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45933803P | 2003-04-01 | 2003-04-01 | |
PCT/EP2004/003418 WO2004087166A1 (en) | 2003-04-01 | 2004-03-31 | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
Publications (1)
Publication Number | Publication Date |
---|---|
IS8096A true IS8096A (is) | 2005-10-27 |
Family
ID=33131880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS8096A IS8096A (is) | 2003-04-01 | 2005-10-27 | Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum |
Country Status (25)
Country | Link |
---|---|
US (2) | US20070066593A1 (is) |
EP (1) | EP1613328B8 (is) |
JP (1) | JP2006522050A (is) |
KR (1) | KR20050121236A (is) |
CN (1) | CN1767833A (is) |
AT (1) | ATE425756T1 (is) |
AU (1) | AU2004226805B2 (is) |
BR (1) | BRPI0408956A (is) |
CA (1) | CA2521371A1 (is) |
DE (1) | DE602004020060D1 (is) |
ES (1) | ES2323270T3 (is) |
HK (1) | HK1090543A1 (is) |
HR (1) | HRP20050872A2 (is) |
IS (1) | IS8096A (is) |
MA (1) | MA27638A1 (is) |
MX (1) | MXPA05010608A (is) |
NO (1) | NO20054994L (is) |
NZ (1) | NZ542554A (is) |
PL (1) | PL1613328T3 (is) |
PT (1) | PT1613328E (is) |
RU (1) | RU2351338C2 (is) |
TN (1) | TNSN05247A1 (is) |
TW (1) | TW200501962A (is) |
WO (1) | WO2004087166A1 (is) |
ZA (1) | ZA200507439B (is) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
GB0424563D0 (en) * | 2004-11-05 | 2004-12-08 | Novartis Ag | Organic compounds |
US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
GB0517740D0 (en) * | 2005-08-31 | 2005-10-12 | Novartis Ag | Organic compounds |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
WO2010019392A1 (en) * | 2008-08-13 | 2010-02-18 | Merck Sharp & Dohme Corp. | Purine derivatives for treatment of alzheimer's disease |
CN102180965B (zh) * | 2011-03-02 | 2014-01-01 | 广州金域医学检验中心有限公司 | 卡马西平免疫原、抗卡马西平特异性抗体、检测试剂及检测试剂盒 |
CN102183659B (zh) * | 2011-03-02 | 2014-07-02 | 广州金域医学检验中心有限公司 | 一种卡马西平检测方法 |
RU2504367C1 (ru) * | 2012-06-05 | 2014-01-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Амурская государственная медицинская академия" Минздравсоцразвития Российской Федерации | Способ коррекции психического состояния пациентов и антиоксидантного статуса при органическом расстройстве личности |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH500196A (de) * | 1969-03-10 | 1970-12-15 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Azepinderivaten |
US3637661A (en) * | 1970-03-04 | 1972-01-25 | Ciba Geigy Corp | 10-hydroxy-10 11-dihydro-dibenzazepine derivative |
US5827819A (en) * | 1990-11-01 | 1998-10-27 | Oregon Health Sciences University | Covalent polar lipid conjugates with neurologically active compounds for targeting |
JP3057471B2 (ja) * | 1993-06-07 | 2000-06-26 | 武田薬品工業株式会社 | アンジオテンシンii介在性諸疾患の予防または治療剤 |
PT101732B (pt) * | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
US5736647A (en) * | 1995-08-07 | 1998-04-07 | Oval Corporation | Vortex flow meter detector and vortex flow meter |
ID28441A (id) * | 1998-10-16 | 2001-05-24 | Janssen Pharmaceutica Nv | Terapi untuk memperbaiki kesadaran |
JP2003519192A (ja) * | 1999-12-30 | 2003-06-17 | プロテオテック・インコーポレーテッド | アルツハイマー病におけるアミロイド症および他のアミロイド症の治療のためのカテキンおよび緑茶抽出物 |
GB0113663D0 (en) * | 2001-06-05 | 2001-07-25 | Novartis Ag | Use of organic compounds |
TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
-
2004
- 2004-03-29 TW TW093108532A patent/TW200501962A/zh unknown
- 2004-03-31 BR BRPI0408956-1A patent/BRPI0408956A/pt not_active IP Right Cessation
- 2004-03-31 AT AT04724599T patent/ATE425756T1/de not_active IP Right Cessation
- 2004-03-31 NZ NZ542554A patent/NZ542554A/en unknown
- 2004-03-31 ES ES04724599T patent/ES2323270T3/es not_active Expired - Lifetime
- 2004-03-31 PL PL04724599T patent/PL1613328T3/pl unknown
- 2004-03-31 MX MXPA05010608A patent/MXPA05010608A/es active IP Right Grant
- 2004-03-31 EP EP04724599A patent/EP1613328B8/en not_active Expired - Lifetime
- 2004-03-31 AU AU2004226805A patent/AU2004226805B2/en not_active Ceased
- 2004-03-31 KR KR1020057018720A patent/KR20050121236A/ko not_active Application Discontinuation
- 2004-03-31 PT PT04724599T patent/PT1613328E/pt unknown
- 2004-03-31 JP JP2006504935A patent/JP2006522050A/ja active Pending
- 2004-03-31 CA CA002521371A patent/CA2521371A1/en not_active Abandoned
- 2004-03-31 CN CNA2004800084961A patent/CN1767833A/zh active Pending
- 2004-03-31 US US10/550,380 patent/US20070066593A1/en not_active Abandoned
- 2004-03-31 RU RU2005133478/15A patent/RU2351338C2/ru not_active IP Right Cessation
- 2004-03-31 WO PCT/EP2004/003418 patent/WO2004087166A1/en active Application Filing
- 2004-03-31 DE DE602004020060T patent/DE602004020060D1/de not_active Expired - Fee Related
-
2005
- 2005-09-15 ZA ZA200507439A patent/ZA200507439B/en unknown
- 2005-09-30 TN TNP2005000247A patent/TNSN05247A1/en unknown
- 2005-09-30 MA MA28522A patent/MA27638A1/fr unknown
- 2005-09-30 HR HR20050872A patent/HRP20050872A2/xx not_active Application Discontinuation
- 2005-10-26 NO NO20054994A patent/NO20054994L/no not_active Application Discontinuation
- 2005-10-27 IS IS8096A patent/IS8096A/is unknown
-
2006
- 2006-06-29 HK HK06107393.2A patent/HK1090543A1/xx not_active IP Right Cessation
-
2009
- 2009-04-07 US US12/419,651 patent/US20090192142A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2005133478A (ru) | 2007-06-10 |
ATE425756T1 (de) | 2009-04-15 |
PT1613328E (pt) | 2009-06-15 |
ZA200507439B (en) | 2007-06-27 |
KR20050121236A (ko) | 2005-12-26 |
NZ542554A (en) | 2008-10-31 |
AU2004226805B2 (en) | 2008-03-06 |
AU2004226805A1 (en) | 2004-10-14 |
JP2006522050A (ja) | 2006-09-28 |
TNSN05247A1 (en) | 2007-06-11 |
RU2351338C2 (ru) | 2009-04-10 |
CA2521371A1 (en) | 2004-10-14 |
NO20054994L (no) | 2005-10-26 |
US20090192142A1 (en) | 2009-07-30 |
MXPA05010608A (es) | 2005-11-23 |
TW200501962A (en) | 2005-01-16 |
EP1613328B1 (en) | 2009-03-18 |
ES2323270T3 (es) | 2009-07-10 |
US20070066593A1 (en) | 2007-03-22 |
MA27638A1 (fr) | 2005-11-01 |
BRPI0408956A (pt) | 2006-04-04 |
CN1767833A (zh) | 2006-05-03 |
DE602004020060D1 (de) | 2009-04-30 |
EP1613328A1 (en) | 2006-01-11 |
WO2004087166A1 (en) | 2004-10-14 |
EP1613328B8 (en) | 2009-06-10 |
HK1090543A1 (en) | 2006-12-29 |
PL1613328T3 (pl) | 2009-08-31 |
HRP20050872A2 (en) | 2006-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8096A (is) | Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum | |
NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
NO20073465L (no) | Benzotiazol-derivater | |
BRPI0416212A (pt) | derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação | |
EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
ATE365742T1 (de) | 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren | |
TR200102782T2 (tr) | Bisiklik heterosikleler, bu bileşikleri ihtiva eden farmasötik kompozisyonlar | |
CY1106645T1 (el) | Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος | |
ATE402176T1 (de) | Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten | |
DE60324014D1 (de) | Heterocyclische verbindungen alsccr5-antagonisten | |
DE602004020685D1 (de) | Substituierte 1h-pyrroloä3,2-b, 3,2-c und 2,3-cüpyridin-2-carbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon | |
NO20032261L (no) | Medisinske preparater | |
ATE541567T1 (de) | Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten | |
BR0210392A (pt) | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto | |
MY133512A (en) | Non-steroidal il-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors | |
ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
TW200519101A (en) | Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
EA200601687A1 (ru) | Тетрагидроизохинолиновые и тетрагидробензазепиновые производные (варианты), фармацевтическая композиция и фармацевтический набор, лекарственное и эталонное средство для тест-систем на их основе, способ лечения и профилактики заболевания, при котором благоприятна понижающая регуляция или ингибирование экспрессии или функции рецептора igf-1 | |
BRPI0514380A (pt) | amidas de ácido 5- e 6-amnoalquil indol-2-carboxìlico 3-substituìdo e análogos relacionados como inibidores de caseìna quinase i | |
TW200519102A (en) | Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
ATE535242T1 (de) | Medizinische zusammensetzung zur prävention des übergangs zu einer operativen behandlung bei prostatahypertrophie | |
BR0314930A (pt) | Derivados de pirazol e seu uso como agentes terapêuticos para doenças mediadas por hiv | |
NO20061966L (no) | Bicyklo[3.1.1.]heptansubstituerte benzimidazolon- og kinazolinonderivater som agonister for humane ORL1 reseptorer | |
EA200900313A1 (ru) | Производные бензо[1,2,3]тиадиазина | |
EA200500235A1 (ru) | Новые производные пиперазинона для лечения нарушений, связанных с 5-ht-рецептором |